0000000001205048

AUTHOR

A. Frasheri

showing 11 related works from this author

Andamento nel tempo dell’approccio alla coronarografia diagnostica in relazione ai progressi della PTCA

2001

coronarografia diagnostica PTCA
researchProduct

Coronarografia diagnostica e conseguenti scelte terapeutiche dopo l’avvento degli stent alla rapamicina: approccio attuale ed evoluzione degli ultimi…

2003

Coronarografia diagnostica stent rapamicina terapia
researchProduct

LDL size and subclasses in patients with abdominal aortic aneurysm

2009

Abstract Since the type of dyslipidemia in patients with abdominal aortic aneurysm (AAA) is still insufficiently defined, we measured plasma lipids and analyzed LDL size and subclasses by gradient gel electrophoresis in 30 male patients (69±6 years, BMI: 27±3) with newly diagnosed AAA and in 26 age- and BMI-matched male healthy controls. Patients with AAA had lower HDL-cholesterol ( p p =.0002) and smaller LDL size ( p p =.0210) in relation to controls. Multivariate analysis also showed that small LDL size was independently associated with the presence of AAA ( p =.0350). Increased levels of small, dense LDL may therefore represent a common feature in patients with AAA.

medicine.medical_specialtySmall dense ldl610 Medicine & healthmacromolecular substancesDense LDLSmallLDL sizeGastroenterology2705 Cardiology and Cardiovascular MedicineAortic aneurysmInternal medicinePlasma lipidsmedicineIn patientcardiovascular diseasesbusiness.industrymedicine.diseaseAbdominal aortic aneurysmEndocrinologymedicine.anatomical_structureMale patientcardiovascular systemAbdominal aortic aneurysmAbdomenlipids (amino acids peptides and proteins)10029 Clinic and Policlinic for Internal MedicineaterosclerosiCardiology and Cardiovascular MedicinebusinessDyslipidemia
researchProduct

Small, dense low-density lipoproteins (LDL) are predictors of cardio- and cerebro-vascular events in subjects with the metabolic syndrome

2009

Summary Objective  Small, dense low-density lipoproteins (LDL) are a feature of the metabolic syndrome (MS) but their predictive role still remains to be established. We performed a 2-year follow-up study in 124 subjects with MS (63 ± 6 years), as defined by the American Heart Association/National Heart, Lung and Blood Institute guidelines, to assess clinical and biochemical predictors of cerebro- and cardio-vascular events. Methods and results  Beyond traditional cardiovascular risk factors, we measured LDL size and subclasses by gradient gel electrophoresis. Clinical events were registered in the 25% of subjects. At univariate analysis subjects with events had increased prevalence of elev…

Blood GlucoseMalemedicine.medical_specialtyEndocrinology Diabetes and Metabolism10265 Clinic for Endocrinology and Diabetology610 Medicine & healthCerebroCoronary artery diseaseEndocrinologyPredictive Value of TestsRisk FactorsInternal medicinemedicineHumansFamily historyLow-density lipoproteins (LDL metabolic syndromeAgedMetabolic SyndromeUnivariate analysisbusiness.industryMiddle Agedmedicine.disease1310 EndocrinologyLipoproteins LDL2712 Endocrinology Diabetes and MetabolismEndocrinologymedicine.anatomical_structureSmall dense low-density lipoproteins cardio events cerebro-vascular events the metabolic syndromeCardiovascular DiseasesPredictive value of testsCirculatory systemFemaleMetabolic syndromebusinessBlood vesselFollow-Up Studies
researchProduct

Family hystory, diabetes and extension of coronary atherosclerosis are strong predictors of adverse events after PTCA: a one year follow-up study

2005

BACKGROUND AND AIM: In this study we addressed some open questions in patients with coronary artery disease (CAD). First, we analysed which of the traditional risk factors was associated with the spreading of coronary stenosis and second, we aimed to identify if any variable was predictive of post-percutaneous transluminal coronary angioplasty (PTCA) clinical events. METHODS AND RESULTS: We collected a consecutive series of patients with CAD (n=301) and in the subgroup of patients undergoing PTCA (n=135) we performed a prospective one-year follow-up study recording cardiovascular morbidity and total mortality. According to the extension of coronary atherosclerosis, we found a significant re…

MaleAdverse eventmedicine.medical_specialtyOne year follow upEndocrinology Diabetes and Metabolismmedicine.medical_treatmentCoronary angiographyCoronary angioplastyMedicine (miscellaneous)Coronary Artery DiseaseBody Mass IndexDiabetes ComplicationsCoronary artery diseaseInternal medicineDiabetes mellitusAngioplastyDiabetes MellitusmedicineHumansObesityProspective Studiescardiovascular diseasesAngioplasty Balloon CoronaryFamily historyAdverse effectCoronary atherosclerosisAgedAnalysis of VarianceSex CharacteristicsUnivariate analysisNutrition and Dieteticsbusiness.industryPredictorsFollow-upCholesterol HDLMiddle AgedPrognosismedicine.diseaseLogistic ModelsTreatment OutcomeCardiologyFemaleCardiology and Cardiovascular Medicinebusiness
researchProduct

THE ATHEROGENIC LIPOPROTEIN PHENOTYPE AS PREDICTOR OF CARDIOVASCULAR EVENTS IN PATIENTS WITH NON-CORONARY FORMS OF ATHEROSCLEROSIS

2008

medicine.medical_specialtyatherogenic lipoproteins cardiovascular events atherosclerosisbusiness.industryInternal medicineInternal MedicinemedicineCardiologyIn patientGeneral MedicineAtherogenic lipoprotein phenotypeCardiology and Cardiovascular MedicinebusinessAtherosclerosis Supplements
researchProduct

We-P11:264 Use of stents with sirolimus is significantly associated with a reduction in mortality and cardiovascular morbidity at 6- and 12-months po…

2006

medicine.medical_specialtybusiness.industryInternal medicinemedicine.medical_treatmentSirolimusInternal MedicinemedicineCardiologyGeneral MedicineCardiology and Cardiovascular MedicinebusinessReduction (orthopedic surgery)medicine.drugAtherosclerosis Supplements
researchProduct

Atherogenic lipoprotein phenotype and LDL size and subclasses in patients with peripheral arterial disease

2006

The type of dyslipidemia in patients with peripheral arterial disease (PAD) is still ill defined. PAD patients often show elevated triglycerides and reduced HDL-cholesterol, two lipid abnormalities usually accompanied by decreased LDL size in the "atherogenic lipoprotein phenotype" (ALP). We investigated (1) whether PAD patients have lower LDL size, (2) altered LDL subclass distribution and (3) the prevalence of ALP. We measured plasma lipids and LDL size and subclasses by gradient gel electrophoresis in 31 adults with intermittent claudication and 31 age-BMI-matched controls. Patients had higher prevalence of hypertension (p = .0132), smoking (p < .0020) and diabetes (p = .0024), with lowe…

Malemedicine.medical_specialtyAtherogenic lipoprotein phenotypeLDL sizeTriglyceridechemistry.chemical_compoundRisk FactorsInternal medicineDiabetes mellitusPeripheral arterial diseaseMedicineHumansRisk factorParticle SizeTriglyceridesAgedDyslipidemiasPeripheral Vascular DiseasesTriglyceridebusiness.industryVascular diseaseCholesterolCholesterol HDLCholesterol LDLMiddle Agedmedicine.diseaseAtherosclerosisIntermittent claudicationHDL-cholesterolEndocrinologyPhenotypechemistrylipids (amino acids peptides and proteins)medicine.symptomCardiology and Cardiovascular MedicinebusinessDyslipidemiaLipoprotein
researchProduct

Association between Tpeak-Tend/QT and major adverse cardiovascular events in patients with Takotsubo syndrome

2020

Background:Conflicting results have been described in the scientific literature regarding the relationship between electrocardiographic parameters and complications in patients with Takotsubo syndrome (TTS). Aim of the present study was to investigate whether there is an association between markers of ventricular repolarization and major adverse cardiovascular events (MACE) during hospitalisation. Methods:A retrospective chart review was conducted on a sample of patients with diagnosis of TTS, based on the fulfilment of the revised Mayo Clinic criteria. MACE included acute heart failure, cardiogenic shock, sustained ventricular tachycardia, ventricular fibrillation, and death. The following…

QT intervalmedicine.medical_specialtyelectrocardiogram030204 cardiovascular system & hematologyQT intervalTpeak–Tend intervalElectrocardiography03 medical and health sciences0302 clinical medicineTakotsubo CardiomyopathyInternal medicineHumansMedicineRepolarizationIn patientcardiovascular diseases030212 general & internal medicineAssociation (psychology)TakotsuboRetrospective StudiesrepolarizationTakotsubo syndromebusiness.industrymajor cardiovascular eventsArrhythmias CardiacGeneral MedicineVentricular FibrillationCardiologyTpeak tendCardiology and Cardiovascular MedicinebusinessActa Cardiologica
researchProduct

Risultati immediati e a lungo termine della valvuloplastica mitralica percutanea: un’esperienza di dieci anni.

2003

metodica valvuloplastica mitralica percutanea
researchProduct

Valutazione dell’outcome a distanza post-PTCA: risultati del follow-up ad un anno

2002

PTCA malattie cardiovascolare
researchProduct